Percutaneous Left Atrial Appendage Occlusion Yields Favorable Neurological Outcomes in Patients with Non-Valvular Atrial Fibrillation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, O.-H. | - |
dc.contributor.author | Kim, Y.D. | - |
dc.contributor.author | Kim, J.-S. | - |
dc.contributor.author | Son, N.-H. | - |
dc.contributor.author | Pak, H.-N. | - |
dc.contributor.author | Joung, B. | - |
dc.contributor.author | Yu, C.-W. | - |
dc.contributor.author | Lee, H.-J. | - |
dc.contributor.author | Kang, W.-C. | - |
dc.contributor.author | Shin, E.-S. | - |
dc.contributor.author | Choi, R.-K. | - |
dc.contributor.author | Lim, D.-S. | - |
dc.contributor.author | Jung, Y.H. | - |
dc.contributor.author | Choi, H.-Y. | - |
dc.contributor.author | Lee, K.-Y. | - |
dc.contributor.author | Cho, B.-H. | - |
dc.contributor.author | Han, S.W. | - |
dc.contributor.author | Park, J.H. | - |
dc.contributor.author | Cho, H.-J. | - |
dc.contributor.author | Park, H.J. | - |
dc.contributor.author | Nam, H.S. | - |
dc.contributor.author | Heo, J.H. | - |
dc.contributor.author | So, C.-Y. | - |
dc.contributor.author | Cheung, G.S.-H. | - |
dc.contributor.author | Lam, Y.-Y. | - |
dc.contributor.author | Freixa, X. | - |
dc.contributor.author | Tzikas, A. | - |
dc.contributor.author | Jang, Y. | - |
dc.contributor.author | Park, J.-W. | - |
dc.date.accessioned | 2021-07-17T04:40:32Z | - |
dc.date.available | 2021-07-17T04:40:32Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2021-07 | - |
dc.identifier.issn | 1738-5520 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/81694 | - |
dc.description.abstract | Background and Objectives: Prior studies have shown that stroke patients treated with percutaneous left atrial appendage occlusion (LAAO) for non-valvular atrial fibrillation (NVAF) experience better outcomes than similar patients treated with warfarin. We investigated the impact of percutaneous left atrial appendage closure on post-stroke neurological outcomes in NVAF patients, compared with non-vitamin K antagonist oral anticoagulant (NOAC) therapy. Methods: Medical records for 1,427 patients in multiple registries and for 1,792 consecutive patients at 6 Korean hospitals were reviewed with respect to LAAO or NOAC treatment. Stroke severity in patients who experienced ischemic stroke or transient ischemic attack after either treatment was assessed with modified Rankin Scale (mRS) scoring at hospital discharge and at 3 and 12 months post-stroke. Results: mRS scores were significantly lower in LAAO patients at 3 (p<0.01) and 12 months (p<0.01) post-stroke, despite no significant differences in scores before the ischemic cerebrovascular event (p=0.22). The occurrences of disabling ischemic stroke in the LAAO and NOAC groups were 36.7% and 44.2% at discharge (p=0.47), 23.3% and 44.2% at 3 months post-stroke (p=0.04), and 13.3% and 43.0% at 12 months post-stroke (p=0.01), respectively. Recovery rates for disabling ischemic stroke at discharge to 12 months post-stroke were significantly higher for LAAO patients (50.0%) than for NOAC patients (5.6%) (p<0.01). Conclusions: Percutaneous LAAO was associated with more favorable neurological outcomes after ischemic cerebrovascular event than NOAC treatment. Copyright © 2021. The Korean Society of Cardiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Korean Society of Circulation | - |
dc.relation.isPartOf | Korean Circulation Journal | - |
dc.title | Percutaneous Left Atrial Appendage Occlusion Yields Favorable Neurological Outcomes in Patients with Non-Valvular Atrial Fibrillation | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000669367100007 | - |
dc.identifier.doi | 10.4070/KCJ.2020.0527 | - |
dc.identifier.bibliographicCitation | Korean Circulation Journal, v.51, no.7, pp.626 - 638 | - |
dc.identifier.kciid | ART002734680 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85107628729 | - |
dc.citation.endPage | 638 | - |
dc.citation.startPage | 626 | - |
dc.citation.title | Korean Circulation Journal | - |
dc.citation.volume | 51 | - |
dc.citation.number | 7 | - |
dc.contributor.affiliatedAuthor | Kang, W.-C. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Atrial appendage | - |
dc.subject.keywordAuthor | Atrial fibrillation | - |
dc.subject.keywordAuthor | Factor Xa inhibitors | - |
dc.subject.keywordAuthor | Stroke | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.